1-4 of 4
Christine L. Clarke
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53-Mutant Tumors and Identifies NRAS as an Oncogenic Driver

Catherine Emmanuel, Yoke-Eng Chiew, Joshy George, Dariush Etemadmoghadam, Michael S. Anglesio, Raghwa Sharma, Peter Russell, Catherine Kennedy, Sian Fereday, Jillian Hung, Laura Galletta, Russell Hogg, Gerard V. Wain, Alison Brand, Rosemary Balleine, Laura MacConaill, Emanuele Palescandolo, Sally M. Hunter, Ian Campbell, Alexander Dobrovic, Stephen Q. Wong, Hongdo Do, Christine L. Clarke, Paul R. Harnett, David D.L. Bowtell, Anna deFazio
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (24): 6618–6630.
https://doi.org/10.1158/1078-0432.CCR-14-1292
Published: 14 December 2014
View article titled, Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and <em>TP53</em>-Mutant Tumors and Identifies <em>NRAS</em> as an Oncogenic Driver
Open the PDF for Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and <em>TP53</em>-Mutant Tumors and Identifies <em>NRAS</em> as an Oncogenic Driver in another window
Includes: Supplementary data
Journal Articles

Molecular Grading of Ductal Carcinoma In situ of the Breast

Rosemary L. Balleine, Lucy R. Webster, Sean Davis, Elizabeth L. Salisbury, Juan P. Palazzo, Gordon F. Schwartz, Dennis B. Cornfield, Robert L. Walker, Karen Byth, Christine L. Clarke, Paul S. Meltzer
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (24): 8244–8252.
https://doi.org/10.1158/1078-0432.CCR-08-0939
Published: 15 December 2008
View article titled, Molecular Grading of Ductal Carcinoma <em>In situ</em> of the Breast
Open the PDF for Molecular Grading of Ductal Carcinoma <em>In situ</em> of the Breast in another window
Includes: Supplementary data
Journal Articles

Poor-Prognosis Estrogen Receptor–Positive Breast Cancer Identified by Histopathologic Subclassification

Lucy R. Webster, Shu-Fen Lee, Clare Ringland, Adrienne L. Morey, Andrew M. Hanby, Graeme Morgan, Karen Byth, Patricia A. Mote, Pamela J. Provan, Ian O. Ellis, Andrew R. Green, Gillian Lamoury, Peter Ravdin, Christine L. Clarke, Robyn L. Ward, Rosemary L. Balleine, Nicholas J. Hawkins
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6625–6633.
https://doi.org/10.1158/1078-0432.CCR-08-0701
Published: 16 October 2008
View article titled, Poor-Prognosis Estrogen Receptor–Positive Breast Cancer Identified by Histopathologic Subclassification
Open the PDF for Poor-Prognosis Estrogen Receptor–Positive Breast Cancer Identified by Histopathologic Subclassification in another window
Includes: Supplementary data
Journal Articles

Histone Deacetylase Inhibitors Decrease Proliferation and Modulate Cell Cycle Gene Expression in Normal Mammary Epithelial Cells

Tracey Davis, Catherine Kennedy, Yoke-Eng Chiew, Christine L. Clarke, Anna deFazio
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (11): 4334–4342.
Published: 01 November 2000
View article titled, Histone Deacetylase Inhibitors Decrease Proliferation and Modulate Cell Cycle Gene Expression in Normal Mammary Epithelial Cells
Open the PDF for Histone Deacetylase Inhibitors Decrease Proliferation and Modulate Cell Cycle Gene Expression in Normal Mammary Epithelial Cells in another window